Your browser doesn't support javascript.
loading
Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.
Cornish, Elisa E; Teo, Kelvin Yc; Gillies, Mark C; Lim, Lyndell L; Nguyen, Vuong; Wickremasinghe, Sanjeewa; Mehta, Hemal; McAllister, Ian L; Fraser-Bell, Samantha.
Affiliation
  • Cornish EE; Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia elisa.cornish@sydney.edu.au.
  • Teo KY; Department of Ophthalmology, Sydney and Sydney Eye Hospital, Sydney, New South Wales, Australia.
  • Gillies MC; Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia.
  • Lim LL; Department of Ophthalmology, Singapore National Eye Centre, Singapore.
  • Nguyen V; Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia.
  • Wickremasinghe S; Department of Ophthalmology, Sydney and Sydney Eye Hospital, Sydney, New South Wales, Australia.
  • Mehta H; Department of Ophthalmology, Centre for Eye Research Australia Ltd, East Melbourne, Victoria, Australia.
  • McAllister IL; Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia.
  • Fraser-Bell S; Department of Ophthalmology, Centre for Eye Research Australia Ltd, East Melbourne, Victoria, Australia.
Br J Ophthalmol ; 107(1): 79-83, 2023 01.
Article in En | MEDLINE | ID: mdl-34340975

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cataract / Macular Edema / Diabetes Mellitus / Diabetic Retinopathy Type of study: Clinical_trials Limits: Humans Language: En Journal: Br J Ophthalmol Year: 2023 Document type: Article Affiliation country: Australia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cataract / Macular Edema / Diabetes Mellitus / Diabetic Retinopathy Type of study: Clinical_trials Limits: Humans Language: En Journal: Br J Ophthalmol Year: 2023 Document type: Article Affiliation country: Australia Country of publication: Reino Unido